| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 06/12/2003 | WO2003048181A1 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents |
| 06/12/2003 | WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 05/22/2003 | US20030096844 Cannabinoid receptor ligands |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/14/2003 | EP0866798B1 Preparation of ester derivatives of steroids |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/08/2003 | WO2003038523A2 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 05/08/2003 | US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering |
| 05/02/2003 | EP1121375B1 High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/29/2003 | US6555699 16-ENE-vitamin D derivatives |
| 04/29/2003 | US6555531 Weight promoting composition, method, and product |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/17/2003 | WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens |
| 04/10/2003 | WO2003029267A2 METHOD OF PRODUCING 17β-(SUBSTITUTED)-3-OXO-Δ1,2-4-AZASTEROIDS AND INTERMEDIATES |
| 04/10/2003 | CA2461221A1 Method of producing 17.beta.-(substituted)-3-oxo-.delta.1,2-4-azasteroids and intermediates |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/03/2003 | US20030065017 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists / antagonists, estrogens and progestins |
| 04/03/2003 | US20030064961 Anaesthetic composition |
| 03/27/2003 | US20030060646 Process for preparing17alpha-acetoxy-11beta-[4-n,n(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene -3,20-dione, intermediates useful in the process , and processes for preparing such intermediates |
| 03/26/2003 | EP1295871A1 Vitamin d derivatives |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/19/2003 | EP1146964B1 Milling process for the production of finely milled medicinal substances |
| 03/19/2003 | CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/13/2003 | US20030050293 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 03/06/2003 | US20030044885 Process to prepare 11beta, 17alpha,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 02/27/2003 | WO2002058634A3 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | CA2448235A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/11/2003 | CA2041135C Method for the photochemical isomerisation of organic compounds under the influence of a photosensitizer |
| 01/16/2003 | US20030013900 Process to prepare11beta,17alpha, 21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 01/15/2003 | EP1275379A2 Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 01/09/2003 | WO2002072084A8 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/03/2003 | CA2451602A1 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 12/27/2002 | WO2002102827A1 PROCESS TO PREPARE 11β, 17α,21-TRIHYDROXY-6α-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 12/27/2002 | WO2002102826A1 PROCESS TO PREPARE 11β,17α,21-TRIHYDROXY-6α-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 12/27/2002 | CA2448039A1 Process to prepare 11.beta., 17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 12/27/2002 | CA2448037A1 Process to prepare 11.beta.,17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 12/25/2002 | CN1096886C Milling process for production of finely milled medicinal substances |
| 12/19/2002 | US20020193616 16-ene-vitamin d derivatives |
| 12/19/2002 | US20020192306 Gastric acid secretion |
| 12/18/2002 | EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 12/18/2002 | EP1265618A1 Anaesthetic composition |
| 12/11/2002 | CN1095847C New 17,20-epoxy derivatives of pregnane |
| 12/10/2002 | US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 12/03/2002 | US6488967 Gastric acid secretion |
| 11/28/2002 | WO2002094769A1 Solid reagent for sampling and derivatization of carbonyl compounds |
| 11/21/2002 | WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 11/14/2002 | US20020168427 Plant extract |
| 11/13/2002 | EP1163257B1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/05/2002 | US6476012 For therapy of symptomology associated with menopause |
| 10/16/2002 | EP1248627A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 10/16/2002 | EP1248626A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
| 10/10/2002 | WO2002078713A1 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 10/10/2002 | WO2002053577A3 Gabaa modulating neurosteroids |
| 10/10/2002 | US20020147355 Animal extracts; uterine contractions; isolation by distillation, flash chromatography |
| 10/10/2002 | US20020146468 Therapy and prophylaxis of diabetes by administering to a human or animal an effective dosage of an extract of plant of the genus Trichocaulon or of the genus Hoodia |
| 10/03/2002 | WO2002076435A2 Lipid profile modulation with steroids |
| 10/03/2002 | US20020143002 Estradiol-16alpha-carboxylic acid esters as locally active estrogens |
| 10/02/2002 | EP1244458A2 Weight promoting composition, method, and product |
| 09/25/2002 | EP1242444A1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 09/19/2002 | WO2002072084A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/18/2002 | EP1239844A1 Process for producing nanometer particles by fluid bed spray-drying |
| 09/10/2002 | US6448419 Reaction with an organolithium reagent and a boron reagent to form the 2-boronyl intermediate which is then oxidized; anticancer |
| 09/03/2002 | CA2118122C Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/22/2002 | US20020114766 Milling process for the production of finely milled medicinal substances |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/13/2002 | US6433200 Antitumor and antirheumatic agents, high binding afinity to vitamin d receptors and weak hypercalcemic activity |
| 08/08/2002 | US20020107229 Multistage preparation for contraception: 2-4 first stage daily dosage including a natural estrogen, form 16-22 second stage daily dosage portions including a natural or synthetic gestogen and a natural estrogen, and a specific third dosage |
| 08/01/2002 | WO2002058634A2 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 07/31/2002 | EP1226155A2 18-nor-steroids as selectively active estrogens |
| 07/31/2002 | CN1361112A Halcinonide producing process |
| 07/31/2002 | CN1361110A Technological process of producing Fludrocortisone 6 Alpha F |
| 07/31/2002 | CN1361109A Recovery process of Dexamethazone-sodium phosphate mother liquor |
| 07/31/2002 | CN1361108A Production process of prednisolone Acetate condensating reduced product |
| 07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1221933A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 07/17/2002 | EP1042353B1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 07/11/2002 | WO2002053577A2 Gabaa modulating neurosteroids |
| 07/11/2002 | US20020091278 Steroid derived antibiotics |
| 07/04/2002 | WO2002051422A1 Preventives/ermedies for inflammatory airway diseases |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/04/2002 | US6399767 Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |